Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer. - Wikidata - awgldk - TriplyDB

Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer.

Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer.

http://www.wikidata.org/entity/Q37125051

about

Medical Oncologists' Experiences in Using Genomic Testing for Lung and Colorectal Cancer Care.

P2860

Q43994049-5FD05A94-1C94-457D-BE1C-727311A4AFA6

P2860

Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer.

http://www.wikidata.org/entity/Q37125051

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Oncologists' Selection of Gene ...... of Stage II Colorectal Cancer.

@en

Oncologists' Selection of Gene ...... of Stage II Colorectal Cancer.

@nl

type

label

Oncologists' Selection of Gene ...... of Stage II Colorectal Cancer.

@en

Oncologists' Selection of Gene ...... of Stage II Colorectal Cancer.

@nl

prefLabel

Oncologists' Selection of Gene ...... of Stage II Colorectal Cancer.

@en

Oncologists' Selection of Gene ...... of Stage II Colorectal Cancer.

@nl

P1433

Q37125051-3335B718-E035-4660-942E-561C3082A20F

P1476

Q37125051-85987559-C881-4235-8CC5-4F0A91A070FA

P2093

Q37125051-37979FB6-9501-4B92-A2BF-B1D4EE690DDC

Q37125051-3B3ECFC5-1D1A-4479-A574-DC19C67E1955

Q37125051-41062787-7E20-44C6-B3C6-0328CAC4EC99

Q37125051-7F6CB0BE-B19E-4922-A62A-89B353900F79

Q37125051-9BB27148-CE6C-4DC9-A2D9-60C5F34E1D49

Q37125051-BBBF202A-24F0-455A-8D1A-B1D657DFFFB7

Q37125051-D2C08E72-5126-4682-9C98-3D24DFFC4E63

Q37125051-DA6B1AC4-257A-401C-95A2-9408874A99D0

P2860

Q37125051-148A168B-F82A-414A-A3B7-927EAEFEFF1B

Q37125051-15DCF894-8676-417A-BEDA-928F1274D009

Q37125051-1681E763-46A4-4A66-8F65-6441823354A4

Q37125051-18FF68D5-726A-41C5-BAE5-F68E98F8861E

Q37125051-1C8D9647-B349-488C-B2C3-9506E11BCB86

Q37125051-2590DB13-9963-497B-9F21-0D5F10EF6344

Q37125051-284A29A5-9C96-4680-9708-FC1CD485B4EE

Q37125051-363C9C7F-E8F5-405F-8CA6-A8E0E601C05F

Q37125051-3751A638-D4BE-4BCC-A219-7D0E1A3BC9A0

Q37125051-3A9C0BF2-3C16-4795-B537-D049633DC36A

P304

Q37125051-05D6C7D2-090B-42D4-B015-A8034F2F0349

P31

Q37125051-802DF6FF-2CEE-4AD2-890F-6C00D5A9A2DA

P356

Q37125051-292C4DBD-CDA1-440E-82B5-86259E30E8F0

P407

Q37125051-A1697FF2-BD50-4171-97D2-82B12CC401D1

P433

Q37125051-6795EEEB-D3B8-4213-8326-797C36861DAB

P478

Q37125051-5D553D12-7ADE-480E-A1F6-0DFC52CA19DC

P50

Q37125051-6AEB3BA7-359B-49C3-B3B4-F8FC11F35FE9

P577

Q37125051-2CA8CFEA-AF84-48C1-925D-5D0525D355FD

P698

Q37125051-9776E9D0-E424-4759-8517-B625B10D4D7B

P921

Q37125051-19DB8B34-E5B4-4AE7-A449-542AFD46400E

P932

Q37125051-86037B0F-9B02-4E11-8F9D-524ADF443676

P356

JOP.2015.007062

P1433

Journal of Oncology Practice

P1476

Oncologists' Selection of Gene ...... of Stage II Colorectal Cancer.

@en

P2093

Aparna R Parikh

http://www.w3.org/2001/XMLSchema#string

Benjamin Kim

http://www.w3.org/2001/XMLSchema#string

Carrie N Klabunde

http://www.w3.org/2001/XMLSchema#string

David A Haggstrom

http://www.w3.org/2001/XMLSchema#string

Katherine L Kahn

http://www.w3.org/2001/XMLSchema#string

Nancy L Keating

http://www.w3.org/2001/XMLSchema#string

Pang-Hsiang Liu

http://www.w3.org/2001/XMLSchema#string

Sapna Syngal

http://www.w3.org/2001/XMLSchema#string

P2860

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field

Microsatellite instability in colorectal cancer

Systematic review of microsatellite instability and colorectal cancer prognosis

Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.

Oncotype DX tumor gene expression profiling in stage II colon cancer. Application: prognostic, risk prediction.

Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

Identification of patients at risk for hereditary colorectal cancer

P304

e308-19, 259-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JOP.2015.007062

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26962170

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4960467

http://www.w3.org/2001/XMLSchema#string